Core Viewpoint - The increasing listing thresholds on NASDAQ and NYSE have created challenges for Chinese companies seeking to raise funds abroad, yet a private high-tech company has successfully entered the international capital market through a precise strategy [1]. Group 1: Company Overview - Yichang Keli Sheng Industrial Group Co., Ltd. has successfully achieved a U.S. listing by acquiring the OTC-listed company Blue Star Global Inc. [1]. - Keli Sheng Group has over 20 years of investment in new materials, focusing on high-temperature materials that provide advanced solutions for industries such as silicon steel, photovoltaics, new energy vehicles, aerospace, and nuclear power [3]. Group 2: Innovative Pathway to Listing - The successful U.S. listing of Keli Sheng Group exemplifies an innovative approach involving "acquisition of an OTC-listed company + asset injection + transfer to NASDAQ + refinancing," serving as a valuable reference for many domestic SMEs [3]. - Compared to traditional IPOs, which can take 12-24 months and involve high compliance costs, acquiring an OTC shell allows companies to gain listing status in a much shorter time frame [5]. Group 3: OTC Market Insights - The U.S. OTC market is a crucial part of the multi-tiered capital market, providing a flexible and mature mechanism for international SMEs like Keli Sheng, acting as a "golden springboard" for entering the U.S. capital market [5]. - The OTC market has hosted numerous multinational giants, indicating its potential for smaller companies to establish a foothold in the U.S. [5]. Group 4: Strategic Recommendations for Chinese SMEs - Chinese SMEs aiming for U.S. listings can follow a "precise selection of pathways and steady upgrades" strategy, starting with the OTC Pink tier for startups and progressing to OTCQB or OTCQX for more mature companies [6]. - The reverse acquisition (backdoor listing) is recommended for companies with limited funds and urgent listing needs, as it allows for immediate capital operation without the barriers of a direct IPO [6]. - Companies should ensure compliance by standardizing financial reports according to U.S. GAAP/IFRS and preparing for dual regulatory requirements to facilitate future transfers and financing [6]. - The OTC market serves as a training ground for compliance, allowing companies to meet necessary metrics before applying for a transfer to NASDAQ or NYSE [6].

Core Insights - The OTC market serves as an optimal transitional platform for companies seeking to go public but currently do not meet the stringent requirements of major exchanges like NASDAQ or NYSE [1] - By the end of 2025, over 48 Chinese companies are expected to complete the "listing-growth-transition" journey through the OTC market, with Yichang Keli Sheng Group's acquisition case exemplifying a successful model for SMEs going public [1][2] Group 1: Market Characteristics - The current U.S. IPO market exhibits a clear "layered adaptation" feature, with NASDAQ planning to raise market cap requirements and the SEC tightening scrutiny on VIE structures and data security, making direct IPOs more suitable for financially robust and stable companies [2] - The SPAC merger model has faced challenges post-2025 due to increased regulations, leading to high redemption rates (averaging over 97%) and significantly higher financing costs, limiting its applicability to a few high-growth sectors [2] Group 2: OTC Market Advantages - The OTC market has emerged as a strong alternative due to its "low threshold, strong flexibility, and progressive" core advantages, especially following the market reforms implemented on July 1, 2025, which clarified the tier structure into four segments: OTCQX, OTCQB, OTCID, and Pink Limited Market [2] - The listing process in the OTC market is efficient and controllable, primarily involving two pathways: direct listing and reverse merger [2] Group 3: Listing Process - Direct listing requires preliminary preparation, including team assessment and application for listing [3] - Reverse mergers provide a faster route to listing, potentially completing in as little as three months, suitable for companies needing quick access to capital markets [3] - The compliance listing process involves SEC document registration, audit compliance review, and stock code changes [5] Group 4: Transition to Major Exchanges - The OTC market's core value lies in its "stepping stone" attribute, allowing companies to achieve tiered growth and transition to major exchanges, with clear and quantifiable conditions for moving from OTCQB to NASDAQ [5] - Companies can apply for transition to NASDAQ by meeting any of the following criteria: net assets of $5 million, cumulative net profit exceeding $750,000 over two years with net assets of $4 million, or a market cap of $50 million with net assets of $4 million, along with additional requirements [5]

Core Insights - The U.S. IPO market is expected to experience explosive growth in 2025, with a total of 531 companies filing for IPOs with the SEC, representing a year-on-year increase of 55.72% [1] - Chinese companies are a significant contributor, with 147 applications, accounting for 27.68% of the total, making them the largest source of IPOs from outside the U.S. [1] - Among the 147 Chinese applicants, 89 are operational entities, and 24 have successfully listed on U.S. exchanges, including notable companies like Cha Tea (CHA), Pomegranate Cloud Medical (POM), and Giant Dragon Online (JLHL) [1] - However, 24 Chinese companies faced rejection from the SEC due to incomplete information in their "blank prospectuses," highlighting the importance of compliance in information disclosure for successful U.S. listings [1] - This trend reflects the global demand for quality enterprises and the vitality of the Chinese economy, indicating that going public in the U.S. remains a crucial path for internationalization [1] - Compliance and thorough information disclosure will be key factors for success in future U.S. listings [1]

Group 1 - Three Chinese companies submitted applications for listing in the US during the week of December 22-28, including one SPAC [1] - Student Living EduVation (Holdings) Corporation, established in 2016 and headquartered in Hong Kong, plans to list on NASDAQ under the temporary code SLED.RC, focusing on student accommodation and property management services [2] - AOJE INC, founded on May 9, 2019, in Jiangsu, aims to list on NASDAQ under the code AOJE, specializing in the manufacturing of copper industrial components for furniture and industrial applications [2] Group 2 - Albert Origin Acquisition Corporation, a SPAC established by a Chinese team, submitted its prospectus to the SEC on December 23, 2025, planning to raise $60 million by issuing 6 million units at $10 per share [3] - The SPAC aims to complete acquisitions of mature companies in North America, Europe, Asia, and Oceania within 18 months, focusing on firms with international expansion potential and sustainable development logic [4] - The core promoter, Bo Yan, holds 100% of the company prior to the IPO and has experience in cross-border investment and corporate operations [4]

Group 1 - The US IPO market remains active in 2025, with 531 companies filing for IPOs, representing a year-on-year increase of 55.72% [1] - Companies from 18 countries and regions have applied for IPOs, with China being the largest source of IPOs outside the US, contributing 147 companies, which accounts for 27.68% of the total [1] - Singapore ranks second with 35 applications, making up 6.59% of the total [1] Group 2 - Among the 147 Chinese applicants, 89 are operational entities, with 24 having completed their listings, including notable brands like Bawang Tea (CHA), Pomegranate Cloud Medical (POM), and Dragon Online (JLHL) [4] - A total of 24 Chinese companies submitted "blank prospectuses," which were rejected by the SEC due to significant information deficiencies, highlighting the importance of compliance in information disclosure during the US listing process [4]

Core Insights - The successful listing of companies on the US stock market is not merely a trend-following adventure but a journey that requires a precise match with the market's expectations and characteristics [1] Group 1: Financial Health - The US stock market emphasizes the importance of sustainable profitability and robust cash flow, requiring clear profit models and healthy financial statements as fundamental thresholds [2] - Even for unprofitable emerging industry companies, it is essential to demonstrate a clear path to profitability, verifiable growth data, and reasonable cost control capabilities [2] Group 2: Industry Adaptability - Investors in the US market show a strong preference for sectors such as high technology, biomedicine, new energy, and consumer innovation, which often receive valuation premiums due to their growth and disruptive potential [4] - Companies in traditional industries must showcase unique competitive advantages, technological barriers, or successful global expansion capabilities to attract international capital [4] Group 3: Corporate Governance - A clear and stable ownership structure, effective internal control systems, and compliance with international disclosure standards are essential for gaining institutional investor trust and meeting US regulatory requirements [6] - Many Chinese concept stocks face risks not from their business operations but from issues related to opaque corporate governance, complex related-party transactions, or compliance loopholes [6] Group 4: Global Expansion Potential - The US market pays close attention to a company's potential for global expansion and execution capabilities, including cross-regional operational experience, brand recognition in overseas markets, and the ability to navigate different regulatory environments [8] - Companies lacking global elements often struggle to stand out in the highly competitive US market [8]

Core Viewpoint - The tightening IPO window on major global exchanges has led many small and medium-sized enterprises to consider the OTCQB market as a viable alternative for public listing, offering a pathway with lower costs and regulatory hurdles compared to traditional IPOs [1]. Group 1: Redefining OTCQB - The OTCQB is not a final destination but a crucial intermediate step for growth-oriented companies transitioning from private to publicly regulated entities [2]. Group 2: Strategic Value of OTCQB - Low-cost trial: Companies can obtain a public trading code at a fraction of the cost and time of traditional IPOs, establishing international governance and financial disclosure systems [3]. - Market valuation: Although initial liquidity may be limited, companies gain a public market price that serves as a benchmark for future financing, acquisitions, and equity incentives [4]. - Paving the way for uplisting: OTCQB serves as a controlled-risk, cost-effective starting point for companies aiming to eventually list on major exchanges [5]. Group 3: Five-Step Ladder to Listing - Step 1: Foundation building (approximately 1-2 months) involves establishing a compliant offshore holding company and a clear international governance structure [7]. - Step 2: Financial translation (approximately 1 month) requires auditing by a PCAOB-recognized firm and converting financial statements to meet U.S. regulatory standards [8]. - Step 3: Regulatory dialogue (approximately 1 month) includes submitting a complete application to FINRA to obtain a unique ticker symbol and qualify for public quotation [9]. - Step 4: Public offering and trading (approximately 1-1.5 months) involves completing an initial public offering under flexible conditions, followed by trading on the OTCQB [10]. - Step 5: Value cultivation and uplisting preparation (1-2 years) focuses on optimizing business operations, attracting analyst attention, maintaining investor relations, and improving metrics to align with major exchange standards [11][12]. Group 4: Uplisting to Major Exchanges - Transitioning from OTCQB to Nasdaq is based on clear, publicly available registration procedures, requiring companies to meet specific financial thresholds, thus reducing uncertainty associated with traditional IPOs [14]. Group 5: Case Studies of Successful Transitions - Case A: Technology company WETG listed on OTCQB in 2020, improved disclosure and investor base, and successfully uplisted to Nasdaq in 2022, significantly enhancing liquidity and market attention [16]. - Case B: Manufacturing company RLEA established credit on the international capital market through OTCQB, secured initial financing, and has applied for Nasdaq uplisting in 2024, demonstrating the pathway's applicability to real economy enterprises [17].

Core Viewpoint - The regulatory framework of the US and China capital markets is continuously adjusting, creating both opportunities and challenges for Chinese companies seeking cross-border financing. The increasing entry barriers for traditional IPOs and the evolving SPAC landscape are pushing smaller enterprises towards the OTC market as a pragmatic entry point into international capital markets [1]. Group 1: Direct IPO (NYSE/NASDAQ) - The traditional IPO route offers significant advantages such as large fundraising potential (with a proposed minimum of $25 million), strong liquidity, and notable brand endorsement, making it suitable for mature tech or manufacturing firms [2]. - However, the disadvantages are considerable, including a lengthy SEC review process of 12-24 months, underwriting fees of 7%-10% of the raised amount, and stringent financial criteria, particularly with the anticipated increase in market capitalization requirements by NASDAQ [2]. - Post-2025, while the resumption of filing windows is expected, compliance issues related to VIE structures and data security reviews remain significant obstacles [2]. Group 2: SPAC Merger Listing - The SPAC model allows for rapid listing through a "shell company fundraising - merger injection" approach, reducing the timeline to 6-9 months and imposing no strict profitability requirements [3]. - Nonetheless, with tightening regulations expected in 2025, SPACs face challenges such as high redemption rates (averaging over 97%) and rising PIPE financing costs (5%-7% of the raised amount), making it more suitable for companies in AI and renewable energy sectors that can effectively communicate their value [3]. Group 3: OTC Market Listing - The OTC market represents the lowest entry barrier, characterized by its "stepping stone" attribute, making it an optimal choice for small and medium-sized enterprises [4]. - For example, the OTCQB listing process typically spans 6-9 months, involving foundational setup (2-3 weeks), issuance and listing (3-6 weeks), requiring 50-100 shareholders and a minimum share price of $1 [5]. - Companies can transition to NASDAQ by meeting specific criteria, such as net assets of at least $5 million or a two-year cumulative net profit of $750,000 alongside net assets of $4 million, with additional requirements including 1 million shares in circulation and a share price of at least $4 [6]. Group 4: Compliance Preparation - The compliance preparation phase for OTC listing takes approximately 4-5 weeks, involving DTC custody applications and drafting the S-1 prospectus [7]. - Following this, the SEC review process lasts about 4 weeks, during which the application is submitted, inquiries are addressed, and a stock code is obtained [7].

Core Viewpoint - The article discusses the strategic choices Chinese companies face when considering listing in the U.S., highlighting the traditional IPO and the emerging SPAC as two main pathways for international expansion and growth [1]. Group 1: Traditional IPO - A Stable Choice - IPOs are a classic model that has been tested over time, offering deep value discovery and structural stability [2]. - Key advantages include transparent valuation based on detailed financial disclosures and market roadshows, which reflect the company's fundamentals and growth potential [3]. - The IPO process involves rigorous due diligence and regulatory scrutiny, leading to a stable equity structure that attracts long-term institutional investors [3]. - Successfully listing on a major exchange after passing SEC scrutiny enhances the company's international brand reputation [3]. Group 2: Potential Challenges of IPO - The IPO process can be lengthy, typically taking 6-12 months or longer, with stringent SEC reviews of financial, legal, and business information [4]. - High intermediary costs and market sentiment can create uncertainty regarding the success of the issuance and pricing, with risks of delays or lower-than-expected valuations during market turbulence [4]. Group 3: SPAC - An Efficient Pathway - SPACs provide a more efficient listing option for certain types of companies, allowing for quicker access to public markets [5]. - The process is faster, typically completed within 3-6 months, avoiding the complexities of traditional IPOs [6]. - Valuation is flexible and can be negotiated directly with the SPAC sponsor, making it suitable for high-growth companies with innovative business models that may not yet be profitable [6]. - SPACs offer a viable listing route for companies that do not fully meet traditional IPO financial criteria but possess disruptive technologies [6]. Group 4: Potential Risks of SPAC - Merging with a SPAC requires shareholder approval, and doubts about the target company's quality can lead to significant redemptions, risking transaction failure or reduced financing [7]. - Initial stock price volatility may be high post-listing, and companies must bear some operational and incentive costs associated with the SPAC [7]. - Despite a faster process, companies still undergo rigorous business, financial, and legal due diligence to meet regulatory requirements [7]. Group 5: Choosing Between IPO and SPAC - The choice between IPO and SPAC is not a simple good or bad evaluation but should align with the company's strategic situation [10]. - Companies suited for IPOs typically have mature business models, stable growth records, and robust financial systems, seeking solid valuations and stable investor structures without urgency for short-term listing [10]. - Companies that may prefer SPACs are often in high-growth sectors (e.g., renewable energy, biotech) and may not be profitable yet but have clear future growth trajectories, requiring quick capital access to seize market opportunities [10].

Core Viewpoint - The door for Chinese companies to list in the U.S. has reopened after being closed for seven months due to regulatory disputes between China and the U.S. [1] Group 1: Background of the Situation - The previous freeze was caused by tensions between China and the U.S., primarily over the U.S. demand to inspect the audit papers of Chinese companies, which China deemed a national security issue [2][4]. - Additionally, new regulations in China required companies to obtain approval from the China Securities Regulatory Commission (CSRC) before listing abroad, leading to a halt in applications since April [3][4]. Group 2: Current Developments - A recent agreement between China and the U.S. in October has provided a mutually acceptable method for inspecting audit papers, alleviating the major crisis of potential delisting [5]. - The CSRC has resumed processing applications, signaling a restart of the listing process for companies that had been waiting [5]. Group 3: New Listing Requirements - Companies seeking to list in the U.S. now face stricter requirements from both the CSRC and U.S. exchanges like NASDAQ: - The CSRC will conduct thorough checks on the company's ownership structure, shareholder backgrounds, business scope, and data security practices [5]. - NASDAQ has raised the minimum fundraising requirement for initial public offerings (IPOs) to $25 million, up from no hard requirement previously [5][9]. Group 4: Opportunities for Companies - Despite the increased scrutiny, the reopening of the listing process presents opportunities for companies that are in urgent need of capital, particularly in sectors like biotechnology and technology [5]. - Companies with straightforward business models, such as SPACs, are also well-positioned to take advantage of the new environment [5]. Group 5: Market Context - The U.S. government has resumed liquidity injections into the market following the end of a government shutdown, creating a favorable environment for new listings [6]. - The reopening of the listing process is seen as a strategic opportunity for companies that can meet the new requirements and are looking for international market recognition [6][7]. Group 6: Proposed Changes in NASDAQ Rules - NASDAQ has proposed new rules that include: - Increasing the minimum public float for companies listing based on net profit from $5 million to $15 million [9]. - Accelerating delisting procedures for companies with market values below $5 million [9]. Group 7: Listing Pathways - Companies can consider various pathways for listing, including direct IPOs, SPAC mergers, and reverse takeovers [10]. - The direct IPO process involves several key stages, including preparation, submission of registration documents, roadshows, and final pricing [11][14]. Group 8: Strategic Recommendations - Companies should reassess their fundraising strategies in light of the new $25 million minimum requirement and consider alternative markets such as the New York Stock Exchange or Hong Kong Stock Exchange [15][17]. - For smaller companies that may struggle to meet the new IPO requirements, exploring SPAC mergers could provide a viable alternative for going public [18].